• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    MicuRx to Present 15 Studies at ESCMID Global 2025

    PR NEWSWIRE

    MicuRx Contezolid Ph 3 Trial Passes Safety Review For DFI Treatment

    PR NEWSWIRE

    MicuRx Positive Results of Ph 3 Trial for Contezolid in Skin & Soft Tissue Inf.

    BIOSPACE

    MicuRx Announces Receipt of FDA’s Fast Track Designations for Contezolid

    BUSINESSWIRE

    Hong Kong exchange picks up steam with two biotech IPOs from Innovent, MicuRx

    ENDPTS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.